US forces on Saturday stopped an oil tanker off the coast of Venezuela for the second time in less than two weeks, following President Donald Trump’s announcement of a blockade on sanctioned vessels.

3I/ATLAS has passed its closest point to Earth, meaning we will soon lose sight of it for good. Some scientists want to send a spacecraft to chase down the alien comet — or the next interstellar ...

ConocoPhillips employees in the North Slope oil fields are moving to form a bargaining unit after the oil company acknowledged that it had sent layoff notices to some of those workers amid plans to ...

Videos shared with the BBC shows a police boat circling a small boat in a shallow canal near the sea in Gravelines France is backing away from a recent commitment to intervene more forcefully at sea ...

The Intercept dropped its most significant story in its three-year history on Tuesday. The website published a piece based on leaked NSA documents that detailed what appeared to be a previously ...

Crew members on flotilla vessel Conscience after intercepted by Israeli forces A new flotilla heading for the Gaza Strip with food and medical supplies on board has been intercepted by Israeli forces.

Anna Coren, CBS News foreign correspondent based in Hong Kong, is an Emmy Award-winning international correspondent who covers the Asia-Pacific region. East China Sea — Over the deep blue waters of ...

The Israeli Navy is ready to intercept an activist mission sailing dozens of boats to Gaza to challenge Israel’s blockade of the Strip, IDF Spokesman Brig. Gen. Effie Defrin says in a press conference ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

After years of regulatory struggles for Intercept Pharmaceuticals and its liver disease drug Ocaliva (obeticholic acid), the FDA has called time on the drug's run in the U.S. market. The agency placed ...

MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary of Alfasigma S.p.A., today announced its decision to voluntarily ...